Brain tumor segmentation in Sub-Saharan Africa patient population: The BraTS-Africa challenge

Read full text
Authors: Maruf Adewole, Jeffrey D. Rudie, Anu Gbadamosi, Dong Zhang, Confidence Raymond, Oluyemisi Toyobo, O. Omidiji, Rachel Akinola, Mohammad Abba Suwaid, Feyisayo Daji, Adaobi Emegoakor, Kenneth Aguh
+37 more Nancy Ojo, Chinasa Kalaiwo, Gabriel Babatunde, Afolabi Ogunleye, Yewande Gbadamosi, Kator Paul Iorpagher, Mayomi Onuwaje, Bamidele Betiku, Rachit Saluja, Dominic LaBella, Evan Calabrese, Ujjwal Baid, Spyridon Bakas, Bjoern Menze, Abiodun Fatade, Farouk Dako, Udunna Anazodo, BraTS Organizers, Maria Correia De Verdier, Huang Raymond, Yury Velichko, Mariam Aboian, A Moawad, Keyvan Farahani, Jake Albrecht, Verena Chung, Benedikt Wiestler, Marius George Linguraru, Anahita Fathi Kazerooni, Gian-Marco Conte, Hongwei Li, Juan Eugenio Iglesias, Syed Muhammad Anwar, Florian Kofler, Alejandro Aristizabal, Hasan Kassem, Alex Karargyris
Cited by: 38
References: 38

Abstract

Background: Automated brain tumor segmentation on multi-parametric magnetic resonance imaging (mpMRI) is crucial in assessing patient outcomes and remains a challenge across Sub-Saharan Africa (SSA). Since 2012, the Brain Tumor Segmentation (BraTS) Challenge has evaluated state-of-the-art artificial intelligence (AI) methods to detect, characterize, and classify tumors. However, it is unclear if these methods can generalize, and hence be widely implemented, in SSA populations. To address this, the BraTS-Africa challenge was conducted in 2023 and 2024 to evaluate population-specific AI models for automated segmentation of brain tumors on mpMRI from the region. Methods: Preoperative T1-weighted, T1-contrast enhanced, T2-weighted, and T2-FLAIR brain MRI scans of 115 patients diagnosed with adult diffuse glioma were curated, annotated, and utilized for the Challenge. Participants were invited to develop and validate their methods. The participating teams were evaluated using weighted Dice Score Coefficient (DSC) and 95% Hausdorff Distance (HD95). Results: In the 2023 challenge a total of 9 teams with participants from 12 countries met the submission criteria and were ranked. The 2024 challenge featured 6 teams from 7 countries. Compared to 2023, the six top ranked methods from 2024 had higher DSC (9.4%) and lower HD95 (57.21%). Conclusions: Together, the 2023 and 2024 challenges provided a unique opportunity to include brain mpMRI glioma cases from SSA in global efforts to develop and evaluate AI methods for the detection of glioma boundaries and their quantification, where the potential of AI solutions to transform healthcare into resource-limited settings is more likely.

Fields of Study & Subjects

AI in cancer detection COVID-19 diagnosis using AI Digital Imaging for Blood Diseases

Publication details

Journal / source
Neuro-Oncology Advances
Publisher
Oxford University Press (OUP)
Volume
8
Issue
1
Pages
vdag082–vdag082
Publication date
1 January 2026
Language
EN